dacarbazine has been researched along with Colorectal Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 6 (19.35) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 16 (51.61) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Amatu, A; Barault, L; Bardelli, A; Bartolini, A; Battuello, P; Bonoldi, E; Cassingena, A; Crisafulli, G; Di Nicolantonio, F; Germano, G; Idotta, L; Lazzari, L; Luraghi, P; Macagno, M; Marsoni, S; Mauri, G; Morano, F; Personeni, N; Pessei, V; Pietrantonio, F; Sartore-Bianchi, A; Siena, S; Tosi, F; Valtorta, E; Vitiello, PP; Zampino, MG | 1 |
| Barbaro, B; Barone, C; Basso, M; Calegari, MA; Camarda, F; Cassano, A; Cenci, T; de Pascalis, I; Gori, S; Inno, A; Larocca, LM; Martini, M; Monterisi, S; Orlandi, A; Santini, D; Tonini, G | 1 |
| Amatu, A; Belotti, A; Bencardino, K; Cassingena, A; Chirico, G; Esposito, A; Esteller, M; Moutinho, C; Nichelatti, M; Rusconi, F; Sartore-Bianchi, A; Siena, S | 1 |
| Doyle, TJ; Glynne-Jones, R; Grávalos, C; Hochhauser, D; Pathiraja, K; Potter, V; Sausville, EA; Zhang, L; Zhang, Q | 1 |
| Biondani, P; Bossi, I; Busico, A; Castano, A; de Braud, F; Di Bartolomeo, M; Festinese, F; Gariboldi, M; Gevorgyan, A; Maggi, C; Pacifici, M; Perrone, F; Pietrantonio, F; Tamborini, E | 1 |
| Hromas, R; Jaiswal, AS; Jani, J; Law, BK; Narayan, S; Panda, H; Sharma, J | 1 |
| Dörsam, B; Fahrer, J; Göder, A; Kaina, B; Kraus, A; Nagel, G; Seiwert, N | 1 |
| Amatu, A; Barault, L; Bardelli, A; Bleeker, FE; Cassingena, A; Cassoni, P; De Braud, F; de Witt Hamer, P; Di Nicolantonio, F; Esteller, M; Falcomatà, C; Fiano, V; Milione, M; Moutinho, C; Pietrantonio, F; Rudà, R; Sartore-Bianchi, A; Siena, S; Siravegna, G; Soffietti, R; Venesio, T; Wesseling, P | 1 |
| Berenato, R; Bossi, I; Caporale, M; de Braud, F; Di Bartolomeo, M; Dotti, KF; Federici, S; Festinese, F; Iacovelli, R; Leone, G; Maggi, C; Milione, M; Pellegrinelli, A; Perrone, F; Pietrantonio, F; Tamborini, E | 1 |
| Baryawno, N; Calero, R; Darabi, A; Dyberg, C; Einvik, C; Johnsen, JI; Kogner, P; Kool, M; Milosevic, J; Sandén, E; Siesjö, P; Sveinbjörnsson, B; Wickström, M | 1 |
| Amatu, A; Barault, L; Bardelli, A; Bencardino, K; Bonazzina, E; Cassingena, A; Chirico, G; Cipani, T; Crivori, P; Di Nicolantonio, F; Esteller, M; Gatto, R; Ghezzi, S; Marrapese, G; Moutinho, C; Palmeri, L; Ricotta, R; Sartore-Bianchi, A; Siena, S; Tosi, F; Truini, M | 1 |
| An, X; Ba, Y; Chen, C; Huang, P; Li, C; Li, Y; Wang, D; Wang, F; Xu, R; Zeng, J; Zeng, Z; Zhang, L | 1 |
| Amatu, A; Barault, L; Bardelli, A; Berenato, R; Caporale, M; Cassingena, A; De Braud, F; Di Nicolantonio, F; Falcomatà, C; Ghezzi, S; Milione, M; Nichelatti, M; Pellegrinelli, A; Pietrantonio, F; Sartore-Bianchi, A; Siena, S; Tosi, F | 1 |
| Aderka, D; Beny, A; Blachar, A; Figer, A; Geva, R; Shacham-Shmueli, E | 1 |
| Aneja, R; Banerjee, S; Jaiswal, AS; Narayan, S; Ostrov, DA; Sarkar, FH | 1 |
| Bradshaw, TD; Hummersone, M; Laughton, CA; Madhusudan, S; Stevens, MF; Zhang, J | 1 |
| Borden, EC; Budd, TG; Elson, P; Hollovary, E; Jacobs, B; Mitsuhashi, M; Spiro, T; Triozzi, P; Yi, T | 1 |
| Almassy, R; Barton, S; Batey, MA; Calabrese, CR; Calvert, AH; Canan-Koch, S; Curtin, NJ; Durkacz, BW; Hostomsky, Z; Kumpf, RA; Kyle, S; Li, J; Maegley, K; Newell, DR; Notarianni, E; Skalitzky, D; Stratford, IJ; Thomas, HD; Wang, LZ; Webber, SE; Williams, KJ | 1 |
| Curtin, NJ; Eastman, BW; Golding, BT; Griffin, RJ; Hostomsky, Z; Kyle, S; Li, J; Maegley, KA; Skalitzky, DJ; Webber, SE; White, AW; Yu, XH | 1 |
| Akbulut, H; Buyukcelik, A; Demirkazik, A; Icli, F; Onur, H; Utkan, G; Yalcin, B | 1 |
| Batey, MA; Calabrese, CR; Canan, S; Curtin, NJ; Hostomsky, Z; Kyle, S; Maegley, KA; Newell, DR; Skalitzky, D; Thomas, HD; Wang, LZ; Webber, SE | 1 |
| Ilson, DH; Krol, G; Ku, GY | 1 |
| Ng, W; Steckley, JL; Watling, CJ | 1 |
| Khan, OA; Levitt, NC; Margison, GP; Michael, M; Middleton, MR; Midgley, R; Mortimer, P; Olver, I; Ranson, M; Watson, AJ | 1 |
| Aschele, C; Bolli, E; Guglielmi, A; Mori, A; Nobile, MT; Rosso, R; Sobrero, A; Tixi, L | 1 |
| Brock, CS; Cunningham, VJ; Harte, RJ; Jones, T; Matthews, JC; Meikle, SR; Price, P; Wells, P | 1 |
| Akbulut, H; Arican, A; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoğuz, H | 1 |
| Bocsi, J; Hidvégi, M; Lapis, K; Paku, S; Prónai, L; Rásó, E; Szende, B; Tömösközi-Farkas, R | 1 |
| Gazit, Z; Kedar, E; Notter, M; Schirrmacher, V; Shouval, D; Walter, J; Weiss, DW; Yechezkeli, M | 1 |
| Blackledge, GR; Brampton, MH; Hoffman, R; Newlands, ES; Quarterman, CP; Rustin, GJ; Slack, JA; Smith, DB; Stevens, MF; Stuart, NS | 1 |
| Droz, JP; Herait, P; Kac, JL; Rougier, P; Theodore, C | 1 |
11 trial(s) available for dacarbazine and Colorectal Neoplasms
| Article | Year |
|---|---|
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; DNA Mismatch Repair; DNA-Binding Proteins; Humans; Mutation; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide | 2022 |
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; GTP Phosphohydrolases; Humans; Membrane Proteins; Middle Aged; Mutation; Nausea; Neoplasm Metastasis; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Retreatment; Survival Rate; Temozolomide; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vomiting | 2017 |
Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Constipation; CpG Islands; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; Prognosis; Promoter Regions, Genetic; Treatment Outcome; Tumor Suppressor Proteins | 2013 |
A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoter.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; DNA Methylation; DNA Mismatch Repair; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Temozolomide; Treatment Outcome | 2013 |
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Promoter Regions, Genetic; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins | 2014 |
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Male; Middle Aged; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins | 2016 |
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; Female; Humans; Immunohistochemistry; Male; Middle Aged; Multivariate Analysis; O(6)-Methylguanine-DNA Methyltransferase; Polymerase Chain Reaction; Predictive Value of Tests; Promoter Regions, Genetic; Retrospective Studies; Survival Analysis; Temozolomide | 2017 |
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
Topics: Adult; Aged; Antimony Sodium Gluconate; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Colorectal Neoplasms; Dacarbazine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Stromal Tumors; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Phosphoric Monoester Hydrolases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Recombinant Proteins; Sarcoma; Vinblastine | 2011 |
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dacarbazine; Disease Progression; Female; Humans; Male; Middle Aged; Neoplasm Staging; Purines; Temozolomide; Treatment Failure | 2008 |
Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Treatment Outcome | 1999 |
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Stomach Neoplasms; Temozolomide | 1992 |
20 other study(ies) available for dacarbazine and Colorectal Neoplasms
| Article | Year |
|---|---|
NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells.
Topics: Apoptosis; Benzothiazoles; Cell Cycle; Cell Cycle Checkpoints; Cellular Senescence; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Damage; DNA Polymerase beta; DNA Repair; Enzyme Inhibitors; HCT116 Cells; Humans; Small Molecule Libraries; Sulfhydryl Compounds; Sulfonamides; Temozolomide; Toluene; Triazoles; Tumor Suppressor Protein p53 | 2015 |
Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction.
Topics: Animals; Antineoplastic Agents, Alkylating; Autophagy; Colorectal Neoplasms; Cysteine; Dacarbazine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Glutathione; Guanine; HCT116 Cells; Humans; Male; Mice, Inbred BALB C; Molecular Targeted Therapy; Temozolomide; Thioctic Acid; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2015 |
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Humans; Polymerase Chain Reaction; Prognosis; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins | 2015 |
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Humans; Middle Aged; Temozolomide | 2016 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Celecoxib; Cisplatin; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glucose-6-Phosphate Isomerase; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Irinotecan; Medulloblastoma; Mice; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Pyrans; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Sulfones; Temozolomide; Triazoles; Tumor Suppressor Proteins; Vincristine; Wnt Proteins; Wnt Signaling Pathway | 2015 |
MGMT in colorectal cancer: a promising component of personalized treatment.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Precision Medicine; Prognosis; Proportional Hazards Models; Temozolomide; Tumor Suppressor Proteins | 2016 |
Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine?
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Biopsy; Colectomy; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Female; Humans; Immunohistochemistry; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Tumor Suppressor Proteins | 2011 |
DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; DNA Polymerase beta; Drug Synergism; Female; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, SCID; Molecular Targeted Therapy; Organophosphates; Pyrimidinones; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Certain imidazotetrazines escape O6-methylguanine-DNA methyltransferase and mismatch repair.
Topics: Antineoplastic Agents, Alkylating; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; DNA Mismatch Repair; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Glioma; Humans; Imidazoles; O(6)-Methylguanine-DNA Methyltransferase; Pilot Projects; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Temozolomide | 2011 |
Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azulenes; Benzodiazepines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gamma Rays; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Radiation-Sensitizing Agents; Temozolomide; Transplantation, Heterologous | 2004 |
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors.
Topics: Amides; Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dacarbazine; Drug Synergism; Humans; Lung Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship; Temozolomide | 2004 |
Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Colorectal Neoplasms; Dacarbazine; Disease-Free Survival; Female; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome | 2004 |
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; DNA Repair; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Gamma Rays; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Maximum Tolerated Dose; Mice; Mice, Nude; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship; Temozolomide; Topoisomerase I Inhibitors; Topotecan | 2007 |
Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Dacarbazine; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Temozolomide; Treatment Outcome | 2007 |
Glioblastoma in a patient with a hereditary cancer syndrome.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Colorectal Neoplasms; Combined Modality Therapy; Dacarbazine; Glioblastoma; Headache; Humans; International Normalized Ratio; Male; Neurosurgical Procedures; Pedigree; Temozolomide; Tomography, X-Ray Computed | 2008 |
Dacarbazine and fotemustine in advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dacarbazine; Female; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds | 1993 |
Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.
Topics: Acridines; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Dacarbazine; Feasibility Studies; Female; Fluorouracil; Glioma; Humans; Middle Aged; Spectrum Analysis; Temozolomide; Tomography, Emission-Computed | 1998 |
MSC, a new benzoquinone-containing natural product with antimetastatic effect.
Topics: Animals; Benzoquinones; Colonic Neoplasms; Colorectal Neoplasms; Dacarbazine; Humans; Lectins; Liver Neoplasms; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasm Metastasis; Plant Extracts; Transplantation, Heterologous | 1999 |
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Cytotoxicity, Immunologic; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Humans; Immunotherapy, Adoptive; Interferon Type I; Interleukin-2; Killer Cells, Lymphokine-Activated; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; T-Lymphocytes; Tumor Cells, Cultured | 1992 |
Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins | 1989 |